Section Arrow
Quote
ARWR.NASDAQ
- Arrowhead Pharmaceuticals
Quotes are at least 15-min delayed:2026/08/16 05:07 EDT
Regular Hours
Last
 86.64
+1.05 (+1.23%)
Day High 
87.17 
Prev. Close
85.59 
1-M High
95.4899 
Volume 
818.16K 
Bid
86.64
Ask
88
Day Low
83.78 
Open
84.75 
1-M Low
69.88 
Market Cap 
12.09B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 87.11 
20-SMA 84.87 
50-SMA 80.74 
52-W High 95.4899 
52-W Low 19.42 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.28/-3.86
Enterprise Value
12.41B
Balance Sheet
Book Value Per Share
3.30
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
829.45M
Operating Revenue Per Share
1.81
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
VBIOValion Bio Inc.0.1906+0.0198+11.59%-- 
OTLKOutlook Therapeutics0.7564-0.1324-14.90%-- 
CAPRCapricor Therapeutics6.65+2.44+57.96%-- 
HUMAHumacyte0.6048+0.0548+9.96%-- 
ENSCEnsysce Biosciences0.3999+0.0514+14.75%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products andclinical candidates designed to target different cell types within the body.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.